Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 274,122 shares at $17.35 ($4.8M) on 2020-12-01, disclosed to the SEC on 2020-12-03.
Open-market sale of $4.8M KPTI by EVP, CBO, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.35 | 58,937 | $1.0M | 21.3% |
| 2 | $17.35 | 58,937 | $1.0M | 21.3% |
| 3 | $17.66 | 78,124 | $1.4M | 28.7% |
| 4 | $17.66 | 78,124 | $1.4M | 28.7% |
| Total | $17.53 avg | 274,122 | $4.8M | 100% |
| Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |
| KPTI | SELL | 2020-03-04 | $672K | — | Filing → |